Oryzon Genomics SA (ORY) — Financial Flexibility Index
Oryzon Genomics SA (ORY) has a Financial Flexibility Index of 0.20x as of June 2023. Free cash flow of €5.16 Million (operating CF €-2.41 Million minus capex €7.57 Million) represents 0% of total liabilities (€26.10 Million). Also explore Oryzon Genomics SA net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oryzon Genomics SA Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Oryzon Genomics SA across 13 annual periods. Check strategic asset allocation of Oryzon Genomics SA to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Oryzon Genomics SA (2013–2025)
Year-by-year free cash flow to debt coverage for Oryzon Genomics SA. For the full company profile including market capitalisation, see Oryzon Genomics SA market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.09x | €-2.30 Million | €-2.36 Million | €26.68 Million | ▼ -192.4% |
| 2024 | 0.09x | €2.02 Million | €-5.69 Million | €21.67 Million | ▼ -83.2% |
| 2023 | 0.55x | €13.93 Million | €-574.96K | €25.13 Million | ▲ +38.9% |
| 2022 | 0.40x | €12.42 Million | €-1.85 Million | €31.13 Million | ▲ +18.3% |
| 2021 | 0.34x | €8.13 Million | €-3.63 Million | €24.12 Million | ▲ +39.1% |
| 2020 | 0.24x | €4.41 Million | €-4.82 Million | €18.18 Million | ▼ -99.7% |
| 2019 | 71.18x | €5.65 Million | €-3.93 Million | €79.38K | ▲ +320210.6% |
| 2018 | -0.02x | €-496.46K | €-666.09K | €22.33 Million | ▲ +87.1% |
| 2017 | -0.17x | €-4.60 Million | €-4.71 Million | €26.61 Million | ▼ -580.8% |
| 2016 | -0.03x | €-686.39K | €-5.01 Million | €27.02 Million | ▼ -154.7% |
| 2015 | 0.05x | €610.79K | €523.14K | €13.14 Million | ▼ -95.4% |
| 2014 | 1.00x | €12.17 Million | €12.13 Million | €12.16 Million | ▲ +15.4% |
| 2013 | 0.87x | €12.17 Million | €12.13 Million | €14.04 Million | — |